CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
26.42
-0.52 (-1.93%)
At close: Mar 28, 2025, 4:00 PM
26.77
+0.35 (1.31%)
After-hours: Mar 28, 2025, 4:58 PM EDT
CG Oncology Employees
CG Oncology had 61 employees as of December 31, 2023.
Employees
61
Change
n/a
Growth
n/a
Revenue / Employee
$18,672
Profits / Employee
-$1,443,262
Market Cap
2.01B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CGON News
- 5 days ago - Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy - GlobeNewsWire
- 4 weeks ago - CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 3 months ago - CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 3 months ago - CG Oncology: Positive Phase 3 Outcome Could Lead To BLA Of Cretostimogene - Seeking Alpha
- 3 months ago - CG Oncology Announces Pricing of Public Offering - GlobeNewsWire
- 3 months ago - CG Oncology Announces Proposed Public Offering - GlobeNewsWire
- 4 months ago - Health Rounds: Experimental CG Oncology immunotherapy shows promise in bladder cancer - Reuters
- 4 months ago - SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award - GlobeNewsWire